Unlocking the Biotechnological and Therapeutic Potential of Animal Venoms

An innovative Venovate project driving sustainable innovation in medicine and biotechnology through animal venom research, bridging researchers, pharmaceutical industries, and regulatory bodies.

About Us

VENOVATE is an innovative, European-funded initiative dedicated to unlocking the vast biotechnological and therapeutic potential of animal venoms. While venoms have already delivered life-saving drugs to the market, they remain a largely untapped resource for modern medicine.

Funded by a COST Innovators Grant (European Cooperation in Science and Technology), VENOVATE addresses critical bottlenecks in venom-based drug discovery. It aims to bridge the gap between academic research and industrial commercialization through:

Team & Partners

VENOVATE is an innovative, European-funded initiative dedicated to unlocking the vast biotechnological and therapeutic potential of animal venoms. While venoms have already delivered life-saving drugs to the market, they remain a largely untapped resource for modern medicine.

Funded by a COST Innovators Grant (European Cooperation in Science and Technology), VENOVATE addresses critical bottlenecks in venom-based drug discovery. It aims to bridge the gap between academic research and industrial commercialization through:

Email icon

Open Calls

Interested in collaborating or learning more about Venovate?

Email

contact@venovate.eu

Address

Avenue Louise 149
1050 Brussels, Belgium